Heres the meat of it:
-------------------------------------------------------------------
Study overview and results
Yale School of Medicine used a highly aggressive human GBM tumour explant to generate brain
tumours in mice. The study then tested the effects of PAT-DX1 and low dose radiation on tumour
growth and mouse survival across four different treatment regimens:
• Control: Control vehicle delivered three times a week
• Low dose radiation: Control + a single low dose radiation treatment
• PAT-DX1: PAT-DX1 alone delivered three times a week
• Combination: PAT-DX1 + a single low dose radiation treatment
Figure 1: Reduction in tumour size relative to
control (week 2)
Figure 2: Survival benefit due to treatment
1A GBM tumour explant was used to inoculate the brains of mice and the tumour was imaged weekly.
Figure 1 shows that as a single agent, PAT-DX1 outperformed low dose radiation in tumour
suppression and extended survival. Further, when PAT-DX1 was used in combination with low dose
radiation, an even greater reduction in tumour size and survival was achieved.
Figure 1: Reduction in tumour size relative to
control (week 2)
Figure 2: Survival benefit due to treatment
Figure 1 shows that two weeks after initiation of treatment, low dose radiation, PAT-DX1, and the
combination reduced tumour size by 52%, 87%, and 93% compared to control, respectively.
Figure 2 shows that low dose radiation alone extended mouse survival by 24% (P=0.04), as a single
agent, PAT-DX1 extended survival by 41% (P=0.01), and PAT-DX1 used in combination with low dose
radiation extended survival by 71% (P=0.002). No toxicity associated with PAT-DX1 treatment was
observed.
- Forums
- ASX - By Stock
- Ann: PAT-DX1 significantly improves survival in aggressive GBM
Heres the meat of it:...
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
-0.001(7.69%) |
Mkt cap ! $12.34M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $14.06K | 2.344M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 5791085 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1726400 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 5791085 | 0.006 |
19 | 8631976 | 0.005 |
8 | 4875000 | 0.004 |
7 | 6230016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1726400 | 6 |
0.008 | 2000000 | 2 |
0.009 | 766604 | 2 |
0.010 | 1412000 | 3 |
0.011 | 1080000 | 2 |
Last trade - 10.29am 18/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |